BioPharma Resources

Drug Trial Radar · NCT07363577

Study to Evaluate LB-102 for the Treatment of Adult Patients With Acute Schizophrenia

A Randomized, Double-blinded, Placebo-controlled, Multicenter Study to Evaluate the Antipsychotic Efficacy and Safety of LB 102 in the Treatment of Adult Patients With Acute Schizophrenia

Last checked: Nov 19, 2026Latest source record: Jul 27, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

RecruitingPivotal-lookingPhase 3. Randomized with 456 participants. This is a heuristic, not a regulatory label.

Status

Recruiting

Enrollment

456

Planned (sponsor's estimate)

Start

Mar 25, 2026

Primary completion

Jun 2027

Study completion Oct 2027

Sponsor

Lead sponsor
LB Pharmaceuticals Inc.Industry
Sponsor type
Industry
First posted
Jan 23, 2026

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Sequential
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
All sexes, from 18 years, up to 65 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This is a Phase 3, randomized, double blind, placebo controlled, fixed dose, study designed to evaluate the efficacy, safety, tolerability, and of LB-102 versus placebo for the treatment of adult patients with an acute exacerbation of schizophrenia.

Conditions

  • Schizophrenia

Interventions

  • LB-102 (50 mg tablet)Drug

    LB-102 oral tablet given for six weeks

  • LB-102 (100 mg tablet)Drug

    LB-102 oral tablet given for six weeks

  • PlaceboOther

    Placebo tablet given orally for six weeks

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Change from baseline to Week 6 on the Positive and Negative Syndrome ScaleTime frame: 6 weeks

Locations

13 sites in 1 country. Site status is shown where the registry gives one.

  • Pillar Clinical Research

    Bentonville, Arkansas · Recruiting

  • Pillar Clinical Research

    Little Rock, Arkansas · Recruiting

  • Woodland International Research Group

    Little Rock, Arkansas · Recruiting

  • ProScience Research Group

    Culver City, California · Recruiting

  • CenExel

    Garden Grove, California · Recruiting

  • Synergy San Diego

    Lemon Grove, California · Recruiting

  • Clinical Innovations, Inc.

    Riverside, California · Recruiting

  • Health Synergy Clinical Research

    Boynton Beach, Florida · Recruiting

  • Innovative Clinical Research

    Miami Lakes, Florida · Recruiting

  • Accelerated Clinical Trial

    Snellville, Georgia · Recruiting

  • Pillar Clinical Research

    Chicago, Illinois · Recruiting

  • Arch Clinical Trials

    St Louis, Missouri · Recruiting

  • Neuro-Behavioral Clinical Research

    North Canton, Ohio · Recruiting

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.